Stimdia Medical
Stimulating Patients to Breathe on Their Own.
Stimulating Patients to Breathe on Their Own.
Stimdia Medical is a privately held Health Care company based in Minneapolis, MN, founded in 2015. The company has developed the pdSTIMTM System, a minimally invasive, temporary, neuromuscular stimulation system that has received FDA Breakthrough Device Designation. The pdSTIM System addresses the challenges associated with prolonged mechanical ventilation (MV) by targeting the atrophy and contractile dysfunction of the diaphragm, the primary muscle involved in respiration. This innovative approach aims to restore diaphragmatic function and enhance patients' ability to breathe independently. The latest financial milestone for Stimdia Medical was a significant $16.00M Series B investment led by Solas BioVentures and Draper Triangle on 14 July 2022. This funding infusion is a testament to the potential of the pdSTIM System in revolutionizing respiratory care. While the pdSTIM System has not yet received regulatory clearances or approvals and is not currently for sale in any country, its breakthrough status and the backing of prominent investors position Stimdia Medical as an intriguing player in the evolving landscape of medical technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $16.00M | 2 |
|
14 Jul 2022 |
| Venture Round | $1.90M | - | 18 Dec 2019 | |
| Venture Round | $1.15M | 1 |
|
07 Feb 2018 |
| Seed Round | $1.90M | - | 21 Dec 2015 |
No recent news or press coverage available for Stimdia Medical.
We care about your data, and we'd love to use cookies make your experience better.
